DE69731620D1 - Neue substituierte n-methyl-n-(4-(4-(1h-benzimidazol-2-yl) (1,4)diazepan-1-yl)-2-(aryl)butyl)benzamide zur behandlung von allergischen krankheiten - Google Patents
Neue substituierte n-methyl-n-(4-(4-(1h-benzimidazol-2-yl) (1,4)diazepan-1-yl)-2-(aryl)butyl)benzamide zur behandlung von allergischen krankheitenInfo
- Publication number
- DE69731620D1 DE69731620D1 DE69731620T DE69731620T DE69731620D1 DE 69731620 D1 DE69731620 D1 DE 69731620D1 DE 69731620 T DE69731620 T DE 69731620T DE 69731620 T DE69731620 T DE 69731620T DE 69731620 D1 DE69731620 D1 DE 69731620D1
- Authority
- DE
- Germany
- Prior art keywords
- diazepan
- benzamides
- benzimidazol
- aryl
- butyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60459096A | 1996-02-21 | 1996-02-21 | |
| US78199797A | 1997-01-06 | 1997-01-06 | |
| PCT/US1997/001601 WO1997030991A1 (en) | 1996-02-21 | 1997-01-29 | Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69731620D1 true DE69731620D1 (de) | 2004-12-23 |
Family
ID=27084698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69731620T Expired - Lifetime DE69731620D1 (de) | 1996-02-21 | 1997-01-29 | Neue substituierte n-methyl-n-(4-(4-(1h-benzimidazol-2-yl) (1,4)diazepan-1-yl)-2-(aryl)butyl)benzamide zur behandlung von allergischen krankheiten |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0888338B1 (de) |
| JP (1) | JP2000505083A (de) |
| KR (1) | KR19990087130A (de) |
| CN (1) | CN1143856C (de) |
| AR (1) | AR005897A1 (de) |
| AT (1) | ATE282609T1 (de) |
| AU (1) | AU708738B2 (de) |
| BR (1) | BR9710712A (de) |
| CA (1) | CA2246994C (de) |
| DE (1) | DE69731620D1 (de) |
| HU (1) | HUP9900401A3 (de) |
| IL (1) | IL125605A0 (de) |
| NO (1) | NO983829L (de) |
| NZ (1) | NZ330909A (de) |
| TW (1) | TW440565B (de) |
| WO (1) | WO1997030991A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6423704B2 (en) | 1995-12-20 | 2002-07-23 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases |
| US6194406B1 (en) | 1995-12-20 | 2001-02-27 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease |
| US7030150B2 (en) * | 2001-05-11 | 2006-04-18 | Trimeris, Inc. | Benzimidazole compounds and antiviral uses thereof |
| WO2008090114A1 (en) | 2007-01-24 | 2008-07-31 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
| CN112778279B (zh) * | 2021-01-25 | 2021-09-28 | 苏州正永生物医药有限公司 | 一种依美斯汀化合物的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5879983A (ja) * | 1981-11-06 | 1983-05-13 | Kanebo Ltd | 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物 |
| IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical preparations containing them |
| GB9310713D0 (en) * | 1993-05-24 | 1993-07-07 | Zeneca Ltd | Aryl substituted heterocycles |
| NZ292683A (en) * | 1994-08-25 | 1998-07-28 | Merrell Pharma Inc | Piperidine derivatives |
| US5607936A (en) * | 1994-09-30 | 1997-03-04 | Merck & Co., Inc. | Substituted aryl piperazines as neurokinin antagonists |
-
1997
- 1997-01-29 AU AU22531/97A patent/AU708738B2/en not_active Ceased
- 1997-01-29 KR KR1019980706521A patent/KR19990087130A/ko not_active Application Discontinuation
- 1997-01-29 AT AT97905700T patent/ATE282609T1/de not_active IP Right Cessation
- 1997-01-29 NZ NZ330909A patent/NZ330909A/en unknown
- 1997-01-29 DE DE69731620T patent/DE69731620D1/de not_active Expired - Lifetime
- 1997-01-29 EP EP97905700A patent/EP0888338B1/de not_active Expired - Lifetime
- 1997-01-29 CN CNB971923833A patent/CN1143856C/zh not_active Expired - Fee Related
- 1997-01-29 IL IL12560597A patent/IL125605A0/xx unknown
- 1997-01-29 WO PCT/US1997/001601 patent/WO1997030991A1/en active IP Right Grant
- 1997-01-29 JP JP9530170A patent/JP2000505083A/ja not_active Abandoned
- 1997-01-29 CA CA002246994A patent/CA2246994C/en not_active Expired - Fee Related
- 1997-01-29 BR BR9710712A patent/BR9710712A/pt not_active IP Right Cessation
- 1997-01-29 HU HU9900401A patent/HUP9900401A3/hu unknown
- 1997-02-18 TW TW086101884A patent/TW440565B/zh not_active IP Right Cessation
- 1997-02-19 AR ARP970100646A patent/AR005897A1/es not_active Application Discontinuation
-
1998
- 1998-08-20 NO NO983829A patent/NO983829L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO983829D0 (no) | 1998-08-20 |
| AR005897A1 (es) | 1999-07-21 |
| ATE282609T1 (de) | 2004-12-15 |
| AU2253197A (en) | 1997-09-10 |
| HUP9900401A2 (hu) | 2000-03-28 |
| CN1143856C (zh) | 2004-03-31 |
| NZ330909A (en) | 2001-04-27 |
| TW440565B (en) | 2001-06-16 |
| KR19990087130A (ko) | 1999-12-15 |
| EP0888338A1 (de) | 1999-01-07 |
| CA2246994C (en) | 2002-04-30 |
| JP2000505083A (ja) | 2000-04-25 |
| AU708738B2 (en) | 1999-08-12 |
| CN1211248A (zh) | 1999-03-17 |
| EP0888338B1 (de) | 2004-11-17 |
| WO1997030991A1 (en) | 1997-08-28 |
| IL125605A0 (en) | 1999-03-12 |
| HUP9900401A3 (en) | 2002-10-28 |
| BR9710712A (pt) | 1999-08-17 |
| CA2246994A1 (en) | 1997-08-28 |
| NO983829L (no) | 1998-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE308997T1 (de) | Mittel zur behandlung von erkrankungen der speiseröhre | |
| DE69903543T2 (de) | Formulierungen zur behandlung von magen-speiseröhren reflux | |
| ATE201138T1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose | |
| DE69711034T2 (de) | Wässrige fluorpolymerlösungen zur behandlung von harten oberflächen | |
| ATE292134T1 (de) | Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien | |
| DE69405919T2 (de) | Zusammensetzungen zur Behandlung von Keratinfasern | |
| ATE273276T1 (de) | Cyclobutendion-derivate zur behandlung von artherosclerose | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
| BR9612074A (pt) | Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas | |
| DE69731620D1 (de) | Neue substituierte n-methyl-n-(4-(4-(1h-benzimidazol-2-yl) (1,4)diazepan-1-yl)-2-(aryl)butyl)benzamide zur behandlung von allergischen krankheiten | |
| DE60117122D1 (de) | Verwendung von mirtazapin zur behandlung von schlafstörungen | |
| DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen | |
| ATE230741T1 (de) | 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen | |
| DE69924284D1 (de) | Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten | |
| ATE330938T1 (de) | Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen | |
| DE60005685D1 (de) | Oxazinocarbazole zur behandlung von cns-erkrankungen | |
| DE69714579D1 (de) | Neue substituierte n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)-piperidin-1-yl)-2(aryl)butyl)benzamide zur behandlung von allergischen krankheiten | |
| ATE300531T1 (de) | Isonipecotamide zur behandlung von integrin vermittelten störungen | |
| ATE226440T1 (de) | Zusammensetzung zur behandlung von psoriasis | |
| DE69926996D1 (de) | Verwendung von riluzol zur behandlung der retinalischemie | |
| DE69813354D1 (de) | Mittel zur Behandlung von Herzkrankheiten | |
| DE50003481D1 (de) | Verwendung von schmutzablösenden formulierungen zur behandlung von oberflächen | |
| ATE284706T1 (de) | Neue verbesserte formulierung zur behandlung von thromboembolismus | |
| ZA971321B (en) | Novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamide useful for the treatment of allergic diseases. | |
| DE50211298D1 (de) | N-(indolcarbonyl-)piperazinderivaten zur behandlung von fettsucht |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de |